These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8985988)

  • 41. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective conjugated fatty acids inhibit guinea pig platelet aggregation.
    Li G; Butz D; Dong B; Park Y; Pariza MW; Cook ME
    Eur J Pharmacol; 2006 Sep; 545(2-3):93-9. PubMed ID: 16890934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
    Jagroop IA; Mikhailidis DP
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):295-302. PubMed ID: 18445610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation and characterization of two disintegrins inhibiting ADP-induced human platelet aggregation from the venom of Crotalus scutulatus scutulatus (Mohave Rattlesnake).
    Sánchez EE; Galán JA; Russell WK; Soto JG; Russell DH; Pérez JC
    Toxicol Appl Pharmacol; 2006 Apr; 212(1):59-68. PubMed ID: 16084550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endocrine system--sanguine system relationship: antiaggregant activity of the pineal polypeptidic hormone E5 on blood platelets.
    Neacşu C
    Arch Roum Pathol Exp Microbiol; 1988; 47(2):125-31. PubMed ID: 3250363
    [No Abstract]   [Full Text] [Related]  

  • 46. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
    Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The effect of new synthetic prostanoids on the aggregation activity of human thrombocytes].
    Petrukhina GN; Makarova VA; FReĭmanis IaF; Lozha EV
    Eksp Klin Farmakol; 1995; 58(6):45-8. PubMed ID: 8704613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
    Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
    Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specific impairment of ADP-induced platelet aggregation by cannabinoids.
    Nathan I; Dvilansky A; Lazarowitz J; Lander N; Livne A
    Int J Tissue React; 1986; 8(3):193-8. PubMed ID: 3781759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impairment of platelet behaviour by isosorbide dinitrate.
    Dutrillaux F; Lecompte T; Samama M
    Thromb Haemost; 1989 Feb; 61(1):152-3. PubMed ID: 2665166
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of ADP-triggered blood platelet aggregation by diadenosine polyphosphate analogues.
    Walkowiak B; Baraniak J; Cierniewski CS; Stec W
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1959-62. PubMed ID: 12113818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of N-(3-hydroxy-1,3,5,(10)estratrien-17 beta-yl)-3-hydroxypropyl-amine (prolame) and estradiol-17 beta on platelet aggregation.
    Baños G; De la Peña A; Izaguirre RR; Mandoki JJ; Mendoza-Patiño N; Rubio-Póo C; Fernández JM
    Proc West Pharmacol Soc; 1991; 34():79-83. PubMed ID: 1788347
    [No Abstract]   [Full Text] [Related]  

  • 53. [Antiplatelet agents: specific agonist inhibitors].
    de Almeida PJ; Pires JG
    Arq Bras Cardiol; 1989 Jul; 53(1):55-9. PubMed ID: 2575895
    [No Abstract]   [Full Text] [Related]  

  • 54. Pyrrolo[3,2-c]pyridine derivatives as inhibitors of platelet aggregation.
    Altomare C; Summo L; Cellamare S; Varlamov AV; Voskressensky LG; Borisova TN; Carotti A
    Bioorg Med Chem Lett; 2000 Mar; 10(6):581-4. PubMed ID: 10741558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of nimodipine on the intracellular calcium level and platelet aggregation in ischemic stroke patients].
    Prianikova NA; Dukhanin AS; Stakhovskaia LV; Chekneva NS
    Biull Eksp Biol Med; 1996 Mar; 121(3):317-20. PubMed ID: 8688539
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical evaluation of platelet function. Comparison of aggregation induced by mechanical collision and by exogenous ADP].
    De Simonis SE; Frusconi R; Parenti C
    Quad Sclavo Diagn; 1974 Sep; 10(3):377-92. PubMed ID: 4467215
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro platelet hypoaggregability to ADP after body hypothermia in anaesthesized dogs is due to phenobarbital.
    Gonçalves FS; Almeida-Dias A; Oliveira PD; Pina-Cabral JM
    Thromb Res; 1992 Jun; 66(5):609-12. PubMed ID: 1523615
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of PGF2 alpha and caffeine on platelet aggregation by ADP induced.
    Orts Buchón A; Giménez Tomás I; Vila Pastor J; Orts Llinares A; Juan Quiles J; Esplugues Requena J
    Arch Farmacol Toxicol; 1976 Aug; 2(2):159-68. PubMed ID: 984889
    [No Abstract]   [Full Text] [Related]  

  • 59. [The influence of azlocillin on ADP-induced thrombocyte aggregation in vitro].
    Menz G
    Med Welt; 1980 Oct; 31(44):1602-3. PubMed ID: 7453544
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of anti-platelet agents on shear-induced platelet aggregation].
    Ikeda Y; Handa M; Kawano K; Kamata T; Anyasu H; Araki Y; kawaiY ; Watanabe K
    Rinsho Ketsueki; 1990 Jun; 31(6):787-92. PubMed ID: 2214169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.